Two Next Generation Diagnostic Platforms Available in Europe

Individual samples are accessed independently and in parallel for chemistry and immunoassay testing. This approach optimizes turnaround time and productivity by intelligently accounting for variable sample and test mixes. In addition to its current broad menu, which includes user-defined applications, the Vitros 5600 integrated system will be able to run new tests for earlier detection of diseases.

The Vitros 3600 immunodiagnostic system is designed for medium- to high-volume labs. Three Vitros technologies are combined into a single system: Microwell technology that with enhanced chemiluminescence enables exceptional assay performance with small sample volume requirements across a broad range of diseases; MicroSensor technology that automatically performs sample quality indices checks on the immunoassay system; and Intellicheck technology that verifies analytical performance and reduces error potential by providing real-time operator notification and tracking.

The systems were developed by Ortho Clinical Diagnostics (High Wycombe, UK). David Atkins, Ph.D., vice president of Ortho Clinical Diagnostics, said, "Our mission has always been to give health professionals the highest quality tools to determine the best treatment. The introduction of the Vitros 5600 integrated system and Vitros 3600 immunodiagnostic system continues this mission with next generation instruments that have a broad, world class menu of assays and the capacity to support future high-impact tests."

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers high quality in-vitro diagnostic products that give health care professionals around the world the knowledge they need to make better treatment decisions sooner.

Related Links:
Ortho Clinical Diagnostics